Base
Rule2020-011652020-02-04

Food Labeling: Revision of the Nutrition and Supplement Facts Labels; Small Entity Compliance Guide; Availability

Health and Human Services Department, Food and Drug Administration

Abstract

The Food and Drug Administration (FDA or we) is announcing the availability of a guidance for industry entitled "Food Labeling: Revision of the Nutrition and Supplement Facts Labeling--Small Entity Compliance Guide." The small entity compliance guide (SECG) is intended to help small entities comply with a final rule we issued in the Federal Register of May 27, 2016, entitled "Food Labeling: Revision of the Nutrition and Supplement Facts Labeling."

Action & Dates

Action
Notification of availability.
Dates
The announcement of the guidance is published in the Federal Register on February 4, 2020.

CFR References

Document Excerpt

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Health and Human Services Food and Drug Administration 21 CFR Part 101 [Docket No. FDA-2012-N-1210] AGENCY: Food and Drug Administration, HHS. ACTION: Notification of availability. SUMMARY: The Food and Drug Administration (FDA or we) is announcing the availability of a guidance for industry entitled “Food Labeling: Revision of the Nutrition and Supplement Facts Labeling—Small Entity Compliance Guide.” The small entity compliance guide (SECG) is intended to help small entities comply with a final rule we issued in the Federal Register of May 27, 2016, entitled “Food Labeling: Revision of the Nutrition and Supplement Facts Labeling.” DATES: The announcement of the guidance is published in the Federal Register on February 4, 2020. ADDRESSES: You may submit either electronic or written comments on FDA guidances at any time as follows: Electronic Submissions Submit electronic comments in the following way: Federal eRulemaking Portal: https://www.regulations.gov . Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https://www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else's Social Security number, or confidential business infor

Read full document on FederalRegister.gov →

Related Documents

Other Federal Register documents from the same docket.

Full Document

Citation: 85 FR 6045